June 24, 2023 — Suddenly at the ADA2023 meeting in San Diego, it seems the tides are rolling in to promise more options than ever before for treating obesity. By tides we mean all those drugs targeting the GLP-1 receptors. GLP-1 is shorthand for glucagon-like peptide 1. Most, but not all of these drugs making a splash in San […]
June 21, 2023 — We’re packing our bag for San Diego and the 83rd Scientific Sessions of the American Diabetes Association, which starts on Friday. This is not a meeting that has been a regular habit for ConscienHealth. But this year it seems ADA2023 will be another milestone in the ongoing diabesity merger. That almost too clever term first […]
June 4, 2023 — The future of obesity will look nothing like its past. In fact, right now the contours of this problem are nothing like they were just a few years ago. We are in the midst of great changes, with more to come. So it’s quite a privilege to spend three days peering into the future of […]
June 3, 2023 — In case you missed it, the framework for obesity care is in the midst of great change. The availability of medicines that actually work to an extent never seen before is causing everyone to question presumptions that researchers and specialists have known to be false for some time. But these great changes are giving rise […]
May 28, 2023 — “Money makes the world go around.” Joel Grey and Liza Minnelli explained this in Cabaret. But sorting it out in healthcare – and specifically in obesity care right now – is quite a challenge. A lot of money is in play and so the tension between greed, health, and obesity care is painfully obvious. The […]
May 27, 2023 — Fame is fleeting. Just a few years ago, fake meat was a hot item with great prospects for transforming the future of food. In 2019 in the New York Times, Timothy Egan wrote “Fake Meat Will Save Us.” Other experts suggested burgers were headed for extinction. No wonder the capitalization of Beyond Meat soared to […]
May 23, 2023 — A pair of reports on Monday raised the possibility that we may soon have oral obesity meds that match the remarkable effectiveness of injections. One of these drugs is an oral formulation of semaglutide that’s already available at a much lower oral dose for diabetes under the brand name of Rybelsus. Novo Nordisk makes it. […]
May 20, 2023 — ECO2023 closed today with a clear focus on future progress in obesity. Lee Kaplan offered a view of what that future might look like with a focus on access and delivery of chronic care for obesity. Kaplan told us the future of obesity care lies in getting beyond merely saying that obesity is a disease. […]
May 15, 2023 — We’re headed to Dublin this week for the European Congress on Obesity – ECO2023. At a pace that will surely be overwhelming, we expect to encounter some of the world’s best researchers, clinicians, and patient advocates bringing us new insights. This comes at an exciting time for the field because advanced treatment options are causing […]
May 9, 2023 — With all the sensational reporting about semaglutide and tirzepatide for obesity – often with the emphasis on weight loss – you might think a revolution is underway. Yes, it is coming. But the truth is that it hasn’t even started yet. At present, for a number of reasons, we are barely scratching the surface of […]
